A potential role for GABAB agonists in the treatment of psychostimulant addiction

被引:133
作者
Brebner, K
Childress, AR
Roberts, DCS
机构
[1] Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27157 USA
[2] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada
[3] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
来源
ALCOHOL AND ALCOHOLISM | 2002年 / 37卷 / 05期
关键词
D O I
10.1093/alcalc/37.5.478
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Aims: Here we briefly review the preclinical and clinical evidence that gamma-aminobutyric acid (GABA(B)) agonists may be useful in the treatment of cocaine addiction. An extensive series of studies in rats has demonstrated that baclofen and other GABA(B) agonists reduce cocaine self-administration in an apparently specific manner. Methods: A number of schedules of reinforcement, including fixed-ratio, progressive-ratio and discrete trials procedures, have been used to model various aspects of cocaine reinforcement and addiction. Results: The results show that systemic pretreatment with baclofen can reduce cocaine intake at doses that do not affect responding for other positive reinforcers, such as food. Direct intracerebral injections of baclofen into the ventral tegmental area also produce a specific reduction in cocaine self-administration, suggesting that an inhibition of dopaminergic neurons may be responsible for the effect. Recent clinical evidence and case reports indicate some therapeutic value for baclofen in controlling cocaine intake and craving, although the evidence from controlled clinical trials has been less than convincing. Perhaps the most intriguing data come from human imaging studies, wherein cocaine addicts report increased cocaine craving and activation of orbital-frontal cortex, anterior cingulate and amygdala when shown videotapes of drug paraphernalia and other addicts taking cocaine. The craving is reduced and the limbic activation is eliminated in cocaine-dependent patients who had been taking baclofen (10-20 mg twice daily) for 7-10 days. Conclusions: Systematic clinical studies of GABA(B) agonists are needed to determine the extent to which these drugs might serve as tools to promote abstinence in cocaine users seeking treatment for their addiction. Several areas must still be addressed, including potential side-effects that may limit compliance and whether GABA(B) agonists interfere with other, non-drug-related behaviours.
引用
收藏
页码:478 / 484
页数:7
相关论文
共 54 条
[1]   A critique of fixed and progressive ratio schedules used to examine the neural substrates of drug reinforcement [J].
Arnold, JM ;
Roberts, DCS .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1997, 57 (03) :441-447
[2]   The GABAB agonist CGP 44532 decreases cocaine self-administration in rats:: demonstration using a progressive ratio and a discrete trials procedure [J].
Brebner, K ;
Froestl, W ;
Andrews, M ;
Phelan, R ;
Roberts, DCS .
NEUROPHARMACOLOGY, 1999, 38 (11) :1797-1804
[3]   Effect of baclofen on cocaine self-administration in rats reinforced under fixed-ratio 1 and progressive-ratio schedules [J].
Brebner, K ;
Phelan, R ;
Roberts, DCS .
PSYCHOPHARMACOLOGY, 2000, 148 (03) :314-321
[4]   The GABAB antagonist CGP56433A attenuates the effect of baclofen on cocaine but not heroin self-administration in the rat [J].
Brebner, K ;
Froestl, W ;
Roberts, DCS .
PSYCHOPHARMACOLOGY, 2002, 160 (01) :49-55
[5]   Intra-VTA baclofen attenuates cocaine self-administration on a progressive ratio schedule of reinforcement [J].
Brebner, K ;
Phelan, R ;
Roberts, DCS .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2000, 66 (04) :857-862
[6]  
CAINE SB, 2000, COLL PROBL DRUG DEP
[7]   Effects of baclofen on maintenance and reinstatement of intravenous cocaine self-administration in rats [J].
Campbell, UC ;
Lac, ST ;
Carroll, ME .
PSYCHOPHARMACOLOGY, 1999, 143 (02) :209-214
[8]  
Childress A. R., 1999, Society for Neuroscience Abstracts, V25, P815
[9]  
CHILDRESS AR, 2000, COL PROBL DRUG DEP P
[10]  
CHILDRESS AR, 2000, NATL I DRUG ABUSE RE, P41